Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | AGN | MYL | TEVA | RDY |
| Company | Supernus Pharm | Allergan Plc | Mylan NV Ord Shs | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 30.34 | 193.01 | 15.64 | 16.07 | 69.61 |
| High | 30.57 | 193.38 | 16.15 | 16.57 | 70.03 |
| Low | 28.27 | 191.64 | 15.34 | 16.07 | 69.13 |
| Last | 28.96 | 193.02 | 15.86 | 16.25 | 69.17 |
| Change | -1.04 | +0.03 | +0.31 | +0.25 | -0.29 |
| % Change | -3.47% | +0.02% | +1.96% | +1.56% | -0.42% |
| Volume | 922,400 | 12,442,600 | 26,574,100 | 13,820,198 | 568,352 |
| 20-Day Average Volume | 414,415 | 4,993,145 | 8,612,350 | 11,354,040 | 222,880 |
| Previous Close | 30.00 | 192.99 | 15.55 | 16.00 | 69.46 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | Yes | No | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.99 | 188.05 | 15.15 | 13.86 | 72.37 |
| 20-Day Raw Stochastic | 15.00% | 76.90% | 86.27% | 92.12% | 2.19% |
| 20-Day Relative Strength | 42.33% | 59.14% | 55.75% | 75.48% | 38.05% |
| Weighted Alpha | -12.31 | +28.20 | -23.10 | +118.50 | +18.22 |
| Today's Opinion | Hold | 72% Buy | 40% Sell | 100% Buy | 24% Sell |
| Previous Opinion | 40% Buy | 56% Buy | 64% Sell | 88% Buy | 8% Sell |
| Last Month's Opinion | 80% Buy | 24% Sell | 64% Sell | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.07% since 05/03/24 | +1.73% since 05/01/20 | +4.86% since 11/09/20 | +16.24% since 05/03/24 | -8.03% since 05/03/24 |
| Low | 28.27 on 05/10/24 | 187.75 on 05/04/20 | 15.10 on 11/10/20 | 13.86 on 05/07/24 | 69.03 on 05/09/24 |
| High | 32.87 on 05/09/24 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 16.57 on 05/10/24 | 75.19 on 05/06/24 |
| 1-Month | |||||
| %Chg | -9.05% since 04/10/24 | +6.59% since 04/08/20 | +0.92% since 10/16/20 | +17.33% since 04/10/24 | -4.72% since 04/10/24 |
| Low | 28.27 on 05/10/24 | 181.21 on 04/09/20 | 14.00 on 10/29/20 | 12.51 on 04/19/24 | 69.03 on 05/09/24 |
| High | 32.87 on 05/09/24 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 16.57 on 05/10/24 | 75.43 on 05/03/24 |
| 3-Month | |||||
| %Chg | +3.76% since 02/09/24 | -2.05% since 02/07/20 | -2.07% since 08/14/20 | +35.30% since 02/09/24 | -6.69% since 02/09/24 |
| Low | 26.27 on 02/28/24 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 12.43 on 02/12/24 | 69.03 on 05/09/24 |
| High | 35.44 on 03/21/24 | 202.21 on 02/12/20 | 17.03 on 08/19/20 | 16.57 on 05/10/24 | 77.72 on 02/23/24 |
| 6-Month | |||||
| %Chg | +8.67% since 11/10/23 | +6.48% since 11/08/19 | +4.58% since 05/15/20 | +87.21% since 11/10/23 | +5.68% since 11/10/23 |
| Low | 26.13 on 12/12/23 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 8.55 on 11/13/23 | 64.50 on 12/11/23 |
| High | 35.44 on 03/21/24 | 202.21 on 02/12/20 | 19.24 on 06/08/20 | 16.57 on 05/10/24 | 77.72 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,649,220 | 63,503,972 | 8,586,212 | 17,937,504 | 11,591,346 |
| Shares Outstanding, K | 54,974 | 329,002 | 541,546 | 1,121,094 | 166,878 |
| Annual Sales | 607,520,000 | 16,088,900,000 | 11,500,500,000 | 15,846,000,000 | 2,992,000,000 |
| Annual Net Income | 1,320,000 | -5,271,000,000 | 16,800,000 | -559,000,000 | 548,000,000 |
| Last Quarter Sales | 164,310,000 | 4,351,000,000 | 2,972,100,000 | 4,457,000,000 | 865,780,000 |
| Last Quarter Net Income | 1,170,000 | -317,200,000 | 185,700,000 | 429,000,000 | 165,470,000 |
| 60-Month Beta | 1.01 | 1.20 | 1.45 | 1.04 | 0.57 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 05/08/24 | 5.22 on 02/10/20 | 0.36 on 11/06/20 | 0.48 on 05/08/24 | 0.94 on 05/07/24 |
| Latest Earnings Date | 05/08/24 | 05/07/20 | 11/06/20 | 05/08/24 | 05/07/24 |
| Most Recent Dividend | N/A | 0.740 on 04/15/20 | 0.060 on 06/27/07 | 0.072 on 11/27/17 | 0.410 on 07/28/23 |
| Next Ex-Dividends Date | N/A | 04/15/20 | N/A | 11/27/17 | 07/28/23 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.94 | 3.29 | 6.15 | 17.74 |